{"id":3756,"date":"2019-08-07T15:35:50","date_gmt":"2019-08-07T06:35:50","guid":{"rendered":"https:\/\/www.ina-research.co.jp\/?p=3756"},"modified":"2020-11-20T09:15:34","modified_gmt":"2020-11-20T00:15:34","slug":"agency-agreement-with-level-biotechnology-inc-taiwan","status":"publish","type":"post","link":"https:\/\/www.ina-research.co.jp\/en\/2019_08_07_3756","title":{"rendered":"Agency Agreement with Level Biotechnology Inc., Taiwan"},"content":{"rendered":"\n<p>SNBL INA Ltd. (INA) is pleased to announce the signing of an agency agreement with Level Biotechnology Inc. (LBI), a Taiwanese Contract Research Organization.<\/p>\n\n\n\n<p>1.Market Potential<br> The biopharmaceutical industry in Taiwan is currently growing at an unprecedented rate.  With LBI as our locally-based agent, Taiwanese customers can now access INAs services in nonhuman primates, studies which are required as part of the biopharmaceutical development process.  In this way, INA hopes to establish a mutually-complementary relationship with LBI, and make inroads into this growing market.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>2. About LBI<br> (1) Company Name: Level Biotechnology Inc.<br> (2) Address: No. 80, Lane 169, Kangning St., His-Chih Dist., New Taipei City 221, Taiwan R.O.C.<br> (3) Representative: Chiu Chun-Lung, Chairman\/President<br> (4) Business: Entered into business as a CRO in 2006 with capabilities in rodent, rabbit and dog studies. Strengths in special techniques such as imaging analysis for evaluation of ocular irritation.<br> (5) Establishment: 1989<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>3. Date of Agreement<br> Agency agreement effective as of July 26, 2019.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SNBL INA Ltd. (INA) is pleased to announce the signing of an agency agreement with Level Biotechnology Inc. (LBI), a Taiwanese Contract Research Organization. 1.Market Potential The biopharmaceutical industry in Taiwan is currently growing at an unprecedented rate. With LBI as our locally-based agent, Taiwanese customers can now access INAs services in nonhuman primates, studies which are required as part of the biopharmaceutical development process. In this way, INA hopes to establish a mutually-complementary relationship with LBI, and make inroads into this growing market. 2. About LBI (1) Company Name: Level Biotechnology Inc. (2) Address: No. 80, Lane 169, Kangning St., His-Chih Dist., New Taipei City 221, Taiwan R.O.C. (3)<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/posts\/3756"}],"collection":[{"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/comments?post=3756"}],"version-history":[{"count":5,"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/posts\/3756\/revisions"}],"predecessor-version":[{"id":5267,"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/posts\/3756\/revisions\/5267"}],"wp:attachment":[{"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/media?parent=3756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/categories?post=3756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ina-research.co.jp\/en\/wp-json\/wp\/v2\/tags?post=3756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}